GlassScriptPhysician profile
Stuart A Chalfin
NPI 1699871608
$10,874.37
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,082 · 2020: $6,686 · 2022: $106.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Contura, INC. | $6,520.68 | 2020 | |
| Neotract INC. | $3,320.24 | 2019-2020 | |
| Medtronic USA, INC. | $581.12 | 2019-2020 | |
| Astellas Pharma US INC | $128.86 | 2019-2020 | |
| Medtronic, INC. | $105.58 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $36.16 | 2020 | |
| Pfizer INC. | $31.66 | 2019-2020 | |
| Blue Earth Diagnostics | $24.37 | 2019 | |
| Antares Pharma, INC. | $22.75 | 2019 | |
| Boston Scientific Corporation | $20.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.61 | 2019 | |
| Therapeuticsmd, INC. | $17.50 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.78 | 2019 | |
| Allergan, INC. | $15.57 | 2020 | |
| Janssen Biotech, INC. | $14.15 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Chalfin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.